Abstract
AbstractHuman multidrug resistance protein 5 (hMRP5) effluxes anticancer and antivirus drugs, driving multidrug resistance. To uncover the mechanism of hMRP5, we determine six distinct cryo-EM structures, revealing an autoinhibitory N-terminal peptide that must dissociate to permit subsequent substrate recruitment. Guided by these molecular insights, we design an inhibitory peptide that could block substrate entry into the transport pathway. We also identify a regulatory motif, comprising a positively charged cluster and hydrophobic patches, within the first nucleotide-binding domain that modulates hMRP5 localization by engaging with membranes. By integrating our structural, biochemical, computational, and cell biological findings, we propose a model for hMRP5 conformational cycling and localization. Overall, this work provides mechanistic understanding of hMRP5 function, while informing future selective hMRP5 inhibitor development. More broadly, this study advances our understanding of the structural dynamics and inhibition of ABC transporters.
Funder
National Natural Science Foundation of China
Guangdong Innovative and Entrepreneurial Research Team Program
Natural Science Foundation of Zhejiang Province
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Wang, J. Q. et al. Multidrug resistance proteins (MRPs): structure, function and the overcoming of cancer multidrug resistance. Drug Resist. Updat. 54, 100743 (2021).
2. Kool, M. et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57, 3537–3547 (1997).
3. Lu, J. F., Pokharel, D. & Bebawy, M. MRP1 and its role in anticancer drug resistance. Drug Metab. Rev. 47, 406–419 (2015).
4. Peters, K. W., Qi, J., Johnson, J. P., Watkins, S. C. & Frizzell, R. Role of snare proteins in CFTR and ENaC trafficking. Pflug. Arch. Eur. J. Phy. 443, 65–69 (2001).
5. Chan, K. W., Zhang, H. & Logothetis, D. E. N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits. EMBO J. 22, 3833–3843 (2003).